Logo of Balsm Alofoq Medical Co.
Balsm Alofoq Medical Co. said its board of directors recommended on Oct. 21 a 100% capital increase from SAR 12.5 million to SAR 25 million through a bonus share distribution.
|
Capital Increase Highlights |
|
|
Current Capital |
SAR 12.50 mln |
|
Number of Shares |
1.25 mln |
|
New Capital |
SAR 25 mln |
|
New Number of Shares |
2.50 mln |
|
Percentage of Increase |
100% (1-for-1) |
|
Reason |
Strengthen the company's strategic growth plan and future expansion needs well as reaffirm its financial solvency and financial position. |
|
Method |
Capitalizing SAR 10.15 mln from issue premium balance and SAR 2.35 mln from retain earnings. |
|
Record Date |
Shareholders of record registered with Edaa by the end of second trading day after the record date. |
Fractional shares, if any, will be collected in a single portfolio to be sold at market price. The proceeds will then be distributed among eligible shareholders pro rata within 30 days maximum from the date of determining each shareholder’s eligible shares.
The bonus issue is pending the approval of the competent authorities and the extraordinary general meeting.
Be the first to comment
Comments Analysis: